Asia Pacific Lymphedema Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Condition Type (Primary Lymphedema and Secondary Lymphedema), Treatment Type (Laser Therapy, Compression Devices and Bandaging, Drug Therapy, Physiological Procedures {Lymphovenous Anastomosis (LVA) and Vascularized Lymph Node Transfer (VLNT)}, Debulking Procedures {Surgical Debulking, Liposuction, and Others}, and Others), and End User (Hospitals, Clinics, Clinical Research Organizations, and Others)
Market Introduction
Asia Pacific (APAC) is the fastest-growing regional market for Lymphedema Treatment; and China, India, Japan, South Korea, Australia, and Rest of APAC are the major contributors to the market in this region. Asia Pacific is likely to account for over 11.96% market share of the lymphedema treatment market in 2021 owing to the growing investments from international players in China and India, improving government support in countries, expanding base of CRO services, and advancing healthcare infrastructure. Therefore, the region holds huge potential for the lymphedema treatment market players to grow during the forecast period. Rising treatment options is the major factor driving the growth of the APAC lymphedema treatment market.
The 2019 novel coronavirus (2019-nCoV), officially named COVID-19 by the WHO, has spread to more than 180 countries, including China prompting the WHO to declare the disease a global pandemic. The supply chain disturbances and the tremendous demand for efficient treatments for the therapy of COVID-19 have put the healthcare research industry in a crucial situation in the Asia Pacific region. Prohibitive measures have been taken to control the spread of this pandemic. COVID-19 pandemic has broadly affected those economies in the Asia Pacific region. Countries such as India, China, Japan, South Korea were adversely affected by the pandemic. The socioeconomics was severely affected, rising in negative inflation, GDPs, and a regional unemployment surge. The outbreak has severely affected the medical tourism industry in Asia pacific and imposed supply chain disruptions; moreover, low-income countries face additional challenges due to the shortage of healthcare infrastructure, restrictions imposed by hospitals to the suppliers, decreasing in demand for cardiovascular surgical instruments, and others. There are various research studies on the reduction of surgeries in the Asia Pacific countries. Restrictive measures have been put forth in South Korea, Malaysia, Singapore, the Philippines, and India to prevent disease transmission. These restrictive measures impacted the supply chain and the availability of medical devices in these countries. It has affected disposable incomes and has also resulted in unemployment. Furthermore, business strategies such as acquisitions, mergers, and partnerships are adversely affected by the imposition of complete lockdown. However, increasing vaccination across the region and availability of government reimbursement policies for various diseases is expected to normalize the situation in the Asia Pacific region and will gradually increase the demand for lymphedema treatment.
Get more information on this report : 
Market Overview and Dynamics
The lymphedema treatment market in APAC is expected to grow from US$ 975.11 million in 2021 to US$ 1,546.52 million by 2028; it is estimated to grow at a CAGR of 6.8% from 2021 to 2028. According to the Cleveland Clinic report, lymphedema can develop when there is damage to the lymphatic system or disruption in lymphatic damage. For example, lymph fluids drain into soft tissues, causing swelling and can occur anywhere in the body, with most cases occurring in arms and legs. Apart from that, cancer surgeries, radiation treatments, and other medical conditions raise the risk of lymphedema among patients. Additionally, among the gynecologic oncologic population, an increase in body mass index, insufficient levels of physical activity, and presence of pre-treatment lymphedema may be witnessed as potentially high-risk factors of lymphedema development. For example, oncological surgical procedures such as sentinel lymph nodes biopsy and radical dissection requiring excision of regional lymph nodes or vessels result in the development of secondary lymphedema. According to one report, lymphedema can occur after any cancer or its treatment affecting lymph node drainage. For example, it has been reported that it can occur within days and up to 30 years after the treatment for breast cancer. Also, 80% of patients experience onset within three years of surgery, and the remainder develops edema at a rate of 1% per year. Additionally, a large patient pool suffers from lower-limb lymphedema, particularly women after treatment for gynecological cancer, with the highest prevalence (36%) among vulvar cancer survivors and lowest prevalence (5%) among ovarian cancer survivors. Further, the overall incidence of arm lymphedema ranges from 8% to 56% at two years post-surgery. Furthermore, lymphedema may and do occur in the trunk, in addition to limbs. For example, radiation therapy to the chest wall is associated with the development of edema, particularly in the irradiated breast. Additionally, the healthcare system requires highly advanced treatment products. Therefore, major players are highly focusing on new and innovative product launches and approvals. Furthermore, with surging volume of lymphedema prevalence fuels the demand for lymphedema treatment ultimately contributing for the overall market growth.
Key Market Segments
The APAC lymphedema treatment market is segmented into condition type, treatment type, end-user and country. Based on type, the APAC lymphedema treatment market is segmented into primary lymphedema and secondary lymphedema. The secondary lymphedema segment dominated the market in 2020 and primary lymphedema is expected to be the fastest growing during the forecast period. Based on treatment type, the APAC lymphedema treatment market is segmented into laser therapy, compression devices and bandaging, drug therapy, physiological procedures, debulking procedures, and others. The compression devices and bandaging segment dominated the market in 2020 and debulking procedures segment is expected to be the fastest growing during the forecast period. Further physiological procedures segment is bifurcated into lymphovenous anastomosis (LVA) and vascularised lymph node transfer (VLNT).Based on end-user, the APAC lymphedema treatment market is segmented into hospitals, clinics, clinical research organizations, and others. The hospitals segment dominated the market in 2020 and clinics is expected to be the fastest growing during the forecast period.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on lymphedema treatment market in APAC are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are 3M Company, BSN medical GmbH, Huntleigh Healthcare Limited, Lohmann & Rauscher GmbH & Co. KG, Mego Afek ltd, Sigvaris Group, and Smith & Nephew are among others.
Reasons to buy report
- To understand the APAC lymphedema treatment market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for APAC lymphedema treatment market
- Efficiently plan M&A and partnership deals in APAC lymphedema treatment market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form APAC lymphedema treatment market
- Obtain market revenue forecast for market by various segments from 2021-2028 in APAC region.
APAC Lymphedema Treatment Market Segmentation
APAC Lymphedema Treatment Market –By Condition Type
- Primary Lymphedema
- Secondary Lymphedema
APAC Lymphedema Treatment Market –By Treatment Type
- Laser Therapy
- Compression Devices
- Drug Therapy
- Physiological Procedures
- Lymphovenous Anastomosis (LVA)
- Vascularised Lymph Node Transfer (VLNT)
- Debulking Procedures
- Surgical Debulking
- Liposuction
- Others
- Others
APAC Lymphedema Treatment Market –By End-User
- Hospitals
- Clinics
- Clinical Research Organizations
- Others
APAC Lymphedema Treatment Market -By Country
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
APAC Lymphedema Treatment Market -Company Profiles
- 3M Company
- BSN medical GmbH
- Huntleigh Healthcare Limited
- Lohmann & Rauscher GmbH & Co. KG
- Mego Afek ltd
- Sigvaris Group
- Smith & Nephew
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 APAC Lymphedema Treatment Market – By Condition Type
1.3.2 APAC Lymphedema Treatment Market – By Treatment Type
1.3.3 APAC Lymphedema Treatment Market – By End-User
1.3.4 APAC Lymphedema Treatment Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. APAC Lymphedema Treatment Market – Market Landscape
4.1 Overview
4.2 APAC PEST Analysis
4.3 Experts Opinion
5. APAC Lymphedema Treatment Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Incidence of Lymphedema Cases
5.1.2 Surge in Healthcare Services
5.2 Market Restraints
5.2.1 Lack of Awareness and Skilled Professionals
5.3 Market Opportunities
5.3.1 Rising Treatment Options
5.4 Future Trends
5.4.1 Usage of Robotics for Lymphedema Treatment
5.5 Impact Analysis
6. Lymphedema Treatment Market– APAC Analysis
6.1 APAC Lymphedema Treatment Market Revenue Forecast and Analysis
7. APAC Lymphedema Treatment Market– By Condition Type
7.1 Overview
7.2 APAC Lymphedema Treatment Market, By Condition Type, 2021 & 2028 (%)
7.3 Primary Lymphedema
7.3.1 Overview
7.3.2 Primary Lymphedema: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Secondary Lymphedema
7.4.1 Overview
7.4.2 Secondary Lymphedema: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
8. APAC Lymphedema Treatment Market – By Treatment Type
8.1 Overview
8.2 APAC Lymphedema Treatment Market, By Treatment Type, 2021 & 2028 (%)
8.3 Laser Therapy
8.3.1 Overview
8.3.2 Laser Therapy: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
8.4 Compression Devices and Bandaging
8.4.1 Overview
8.4.2 Compression Devices and Bandaging: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
8.5 Drug Therapy
8.5.1 Overview
8.5.2 Drug Therapy: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
8.6 Physiological Procedures
8.6.1 Overview
8.6.2 Physiological Procedures: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
8.6.2.1 Lymphovenous Anastomosis (LVA)
8.6.2.1.1 Overview
8.6.2.1.2 Lymphovenous Anastomosis (LVA): Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
8.6.2.2 Vascularized Lymph Nodes Transfer (VLNT)
8.6.2.2.1 Overview
8.6.2.2.2 Vascularized Lymph Nodes Transfer (VLNT): Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
8.7 Debulking Procedures
8.7.1 Overview
8.7.2 Debulking Procedures: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
8.7.2.1 Surgical Debulking
8.7.2.1.1 Overview
8.7.2.1.2 Surgical Debulking: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
8.7.2.2 Liposuction
8.7.2.2.1 Overview
8.7.2.2.2 Liposuction: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
8.7.2.3 Others
8.7.2.3.1 Overview
8.7.2.3.2 Others: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
9. APAC Lymphedema Treatment Market – By End User
9.1 Overview
9.2 APAC Lymphedema Treatment Market, By End User, 2021 & 2028 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
9.4 Clinics
9.4.1 Overview
9.4.2 Clinics: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
9.5 Clinical Research Organization (CRO’s)
9.5.1 Overview
9.5.2 Clinical Research Organizations (CRO’s): Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
10. APAC Lymphedema Treatment Market – By Country Analysis
10.1 Overview
10.1.1 Asia Pacific: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Country (%)
10.1.1.1 Japan: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 Japan: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
10.1.1.1.3 Japan: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Condition Type (US$ Million)
10.1.1.1.4 Japan: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Treatment Type (US$ Million)
10.1.1.1.4.1 Japan: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Physiological Procedures (US$ Million)
10.1.1.1.4.2 Japan: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Debulking Procedures (US$ Million)
10.1.1.1.5 Japan: Lymphedema Treatment Market, by End-User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2 China: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 China: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
10.1.1.2.3 China: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Condition Type (US$ Million)
10.1.1.2.4 China: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Treatment Type (US$ Million)
10.1.1.2.4.1 China: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Physiological Procedures (US$ Million)
10.1.1.2.4.2 China: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Debulking Procedures (US$ Million)
10.1.1.2.5 China: Lymphedema Treatment Market, by End-User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3 India Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 India: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
10.1.1.3.3 India: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Condition Type (US$ Million)
10.1.1.3.4 India: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Treatment Type (US$ Million)
10.1.1.3.4.1 India: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Physiological Procedures (US$ Million)
10.1.1.3.4.2 India: Lymphedema Treatment Market Revenue and Forecasts to 2028, by Debulking Procedures (US$ Million)
10.1.1.3.5 India: Lymphedema Treatment Market, by End-User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4 South Korea: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 South Korea: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
10.1.1.4.3 South Korea: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Condition Type (US$ Million)
10.1.1.4.4 South Korea: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Treatment Type (US$ Million)
10.1.1.4.4.1 South Korea: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Physiological Procedures (US$ Million)
10.1.1.4.4.2 South Korea: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Debulking Procedures (US$ Million)
10.1.1.4.5 South Korea: Lymphedema Treatment Market, by End-User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5 Australia: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
10.1.1.5.1 Overview
10.1.1.5.2 Australia: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
10.1.1.5.3 Australia: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Condition Type (US$ Million)
10.1.1.5.4 Australia: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Treatment Type (US$ Million)
10.1.1.5.4.1 Australia: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Physiological Procedures (US$ Million)
10.1.1.5.4.2 Australia: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Debulking Procedures (US$ Million)
10.1.1.5.5 Australia: Lymphedema Treatment Market, by End-User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6 Rest of Asia Pacific: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Asia Pacific: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.3 Rest of Asia Pacific: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Condition Type (US$ Million)
10.1.1.6.4 Rest of Asia Pacific: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Treatment Type (US$ Million)
10.1.1.6.4.1 Rest of Asia Pacific: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Physiological Procedures (US$ Million)
10.1.1.6.4.2 Rest of Asia Pacific: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Debulking Procedures (US$ Million)
10.1.1.6.5 Rest of Asia Pacific: Lymphedema Treatment Market, by End-User – Revenue and Forecast to 2028 (US$ Million)
11. Impact Of COVID-19 Pandemic on APAC Lymphedema Treatment Market
11.1 Overview
12. Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 Smith & Nephew
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 BSN medical GmbH
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Lohmann & Rauscher GmbH & Co. KG
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Sigvaris Group
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Huntleigh Healthcare Limited
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 3M Company
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Mego Afek ltd.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. APAC Lymphedema Treatment Market Revenue and Forecast to 2028 (US$ Million)
Table 2. Japan: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Condition Type (US$ Million)
Table 3. Japan: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Treatment Type (US$ Million)
Table 4. Japan: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Physiological Procedures (US$ Million)
Table 5. Japan: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Debulking Procedures (US$ Million)
Table 6. Japan: Lymphedema Treatment Market, by End-User – Revenue and Forecast to 2028 (US$ Million)
Table 7. China: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Condition Type (US$ Million)
Table 8. China: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Treatment Type (US$ Million)
Table 9. China: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Physiological Procedures (US$ Million)
Table 10. China: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Debulking Procedures (US$ Million)
Table 11. China: Lymphedema Treatment Market, by End-User – Revenue and Forecast to 2028 (US$ Million)
Table 12. India: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Condition Type (US$ Million)
Table 13. India: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Treatment Type (US$ Million)
Table 14. India: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Physiological Procedures (US$ Million)
Table 15. India: Lymphedema Treatment Market Revenue and Forecasts to 2028, by Debulking Procedures (US$ Million)
Table 16. India: Lymphedema Treatment Market, by End-User – Revenue and Forecast to 2028 (US$ Million)
Table 17. South Korea: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Condition Type (US$ Million)
Table 18. South Korea: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Treatment Type (US$ Million)
Table 19. South Korea: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Physiological Procedures (US$ Million)
Table 20. South Korea: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Debulking Procedures (US$ Million)
Table 21. South Korea: Lymphedema Treatment Market, by End-User – Revenue and Forecast to 2028 (US$ Million)
Table 22. Australia: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Condition Type (US$ Million)
Table 23. Australia: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Treatment Type (US$ Million)
Table 24. Australia: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Physiological Procedures (US$ Million)
Table 25. Australia: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Debulking Procedures (US$ Million)
Table 26. Australia: Lymphedema Treatment Market, by End-User – Revenue and Forecast to 2028 (US$ Million)
Table 27. Rest of Asia Pacific: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Condition Type (US$ Million)
Table 28. Rest of Asia Pacific: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Treatment Type (US$ Million)
Table 29. Rest of Asia Pacific: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Physiological Procedures (US$ Million)
Table 30. Rest of Asia Pacific: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Debulking Procedures (US$ Million)
Table 31. Rest of Asia Pacific: Lymphedema Treatment Market, by End-User – Revenue and Forecast to 2028 (US$ Million)
Table 32. Organic Developments Done by Companies
Table 33. Inorganic Developments Done by Companies
Table 34. Glossary of Terms
LIST OF FIGURES
Figure 1. APAC Lymphedema Treatment Market Segmentation
Figure 2. APAC Lymphedema Treatment Market, By Country
Figure 3. APAC Lymphedema Treatment Market Overview
Figure 4. Condition Type Segment led the Market in 2021
Figure 5. China is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Asia Pacific: PEST Analysis
Figure 7. Experts Opinion
Figure 8. Impact Analysis of Drivers and Restraints for APAC Lymphedema Treatment Market
Figure 9. APAC Lymphedema Treatment Market –Forecast and Analysis to 2028
Figure 10. APAC Lymphedema Treatment Market, by Condition Type, 2021 & 2028 (%)
Figure 11. APAC Primary Lymphedema: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 12. APAC Secondary Lymphedema: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 13. APAC Lymphedema Treatment Market, by Treatment Type 2021 & 2028 (%)
Figure 14. APAC Laser Therapy: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 15. APAC Compression Devices and Bandaging: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 16. APAC Drug Therapy: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 17. APAC Physiological Procedures: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 18. APAC Lymphovenous Anastomosis (LVA): Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 19. APAC Vascularized Lymph Nodes Transfer (VLNT): Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 20. APAC Debulking Procedures: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 21. APAC Surgical Debulking: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 22. APAC Liposuction: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 23. APAC Others: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 24. APAC Others: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 25. APAC Lymphedema Treatment Market, by End User, 2021 & 2028 (%)
Figure 26. APAC Hospitals: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 27. APAC Clinics: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 28. APAC Clinical Research Organizations (CRO’s): Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 29. APAC Others: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 30. Asia Pacific Lymphedema Treatment Market Overview, by Country (2021)
Figure 31. Asia Pacific: Lymphedema Treatment Market Revenue and Forecasts to 2028, By Country (%)
Figure 32. Japan: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 33. China: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 34. India: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 35. South Korea: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 36. Australia: Lymphedema Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 37. Rest of Asia Pacific: Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 38. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
- 3M Company
- BSN medical GmbH
- Huntleigh Healthcare Limited
- Lohmann & Rauscher GmbH & Co. KG
- Mego Afek ltd
- Sigvaris Group
- Smith & Nephew
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the APAC lymphedema treatment market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the APAC lymphedema treatment market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the lymphedema treatment market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution